...
首页> 外文期刊>Journal of cardiac failure >Differential Impact of Ultrafiltration and Diuretics on Urine Sodium Excretion in Acute Heart Failure: Insights from CARRESS-HF
【24h】

Differential Impact of Ultrafiltration and Diuretics on Urine Sodium Excretion in Acute Heart Failure: Insights from CARRESS-HF

机译:超滤和利尿剂对急性心力衰竭尿液钠排泄的差异影响:来自校准的洞察力

获取原文
获取原文并翻译 | 示例
           

摘要

IntroductionBy blocking Na resorption in the thick ascending limb of the nephron, loop diuretics (LD) mediate volume loss through natriuresis. In contrast, extracorporeal isotonic volume removal by ultrafiltration (UF) is not renally mediated. Whether these therapies have a differential effect on renal sodium excretion in acute heart failure (AHF) is unknown. HypothesisDiuretic-mediated decongestion will be associated with more sodium excretion than UF mediated decongestion. MethodsA per-protocol analysis of CARRESS-HF (N=188) was performed. Participants were included if they had spot urine Na measured in the core lab and either randomized to UF and had UF output collected without concomitant intravenous LD use, or if randomized to the LD-based pharmacological arm and had urine but not UF output collected. There were N=61, 55, and 51 participants meeting this criteria at baseline, 24 h and 96 h, respectively. Mixed effects modelling determined the association of treatment on serial parameters. ResultsThere were N=20 in the UF arm (age 67y [59-82], 80% male, 55% NICM, Cr 2.1 mg/dL [1.7-2.4], Na 137 mmol/L [134-139]) and N=41 in the pharmacological arm (age 65y [59-76], 73% male, 54% NICM, Cr 2.4 mg/dL [1.9-2.7], Na 138 mmol/L [135-140]). UF was associated with more relative weight loss by 96 h (%*time, P-interaction=0.003), lower urine sodium concentration over time by 24 and 96 h (UNa*time, P-interaction<0.005 for both), and lower fractional excretion of Na by 24 and 96 h (FENa*time, P-interaction<0.005 for both) in comparison to the LD-based pharmacological arm (Figure). ConclusionsUltrafiltration, without concomitant LD use, is associated with less urinary sodium excretion in comparison to LD-based pharmacological decongestion in AHF. Yet, UF was also associated with greater weight loss, which may be reflective of greater cumulative sodium removal via UF. These observations highlight the differential response to sodium renal handling from extracorporeal volume removal than from LDs.
机译:引入下封闭NA吸收的肾上腺升肢,环路利尿(LD)通过Natriuresis调解体积损失。相反,通过超滤(UF)的体外等渗体积除去不肾上介导。这些疗法是否对急性心力衰竭(AHF)中的肾脏排泄有差异影响(AHF)是未知的。假设钠介导的背年将与比UF介导的背包更多的钠排泄有关。方法进行校验组-HF(n = 188)的每协议分析。如果在核心实验室中测量的尿液Na,并且随机测量到UF并在没有伴随的静脉内LD使用的情况下进行UF输出,或者如果被随机收集到LD的药理学臂,则包括参与者,或者收集到LD的药理学臂,并且收集UF输出,并且没有收集到LD的药理学臂。有n = 61,55和51名参与者,分别以基线,24小时和96小时达到此标准。混合效应建模确定了治疗对串行参数的关联。 UF臂中的n = 20(67岁[59-82],80%雄性,55%NiCM,Cr 2.1mg / D1 [1.7-2.4],Na 137mmol / L [134-139])和n = 41在药理学臂(年龄65Y [59-76],73%雄性,54%NiCM,Cr 2.4mg / D1 [1.9-2.7],Na 138mmol / L [135-140])。 UF与96小时的更相对相对的重量损失有关96小时(%*时间,p互动= 0.003),尿液钠浓度随时间的时间增加24和96小时(UNA *时间,对两者的P型相互作用<0.005),和更低与基于LD的药理学臂(图)相比,Na×24和96小时的分数排泄到24和96小时(Fena *时间,P型相互作用<0.005)。结论在没有伴随的LD使用的情况下,与AHF中LD的药理学减肥相比,无需伴随的LD使用,与尿钠排泄有关。然而,UF也与更大的体重减轻有关,其可以反射通过UF的更大累积钠去除。这些观察结果突出了与来自LDS的体外除去的肾脏处理的差异反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号